These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7653779)

  • 1. Rocuronium and rapid sequence induction.
    Playfair PA; Uncles DR
    Anaesthesia; 1995 Jul; 50(7):663. PubMed ID: 7653779
    [No Abstract]   [Full Text] [Related]  

  • 2. Rocuronium in the myasthenic patient.
    Baraka A; Haroun-Bizri S; Kawas N; Hajjar AM; Kawkabani N
    Anaesthesia; 1995 Nov; 50(11):1007. PubMed ID: 8678231
    [No Abstract]   [Full Text] [Related]  

  • 3. The interaction between mivacurium and rocuronium during onset and recovery.
    Mirakhur RK
    Anaesthesia; 1997 Mar; 52(3):280. PubMed ID: 9124674
    [No Abstract]   [Full Text] [Related]  

  • 4. The interaction between mivacurium and rocuronium during onset and recovery.
    England AJ; Feldman SA
    Anaesthesia; 1997 Mar; 52(3):279-80. PubMed ID: 9124673
    [No Abstract]   [Full Text] [Related]  

  • 5. Potency and onset time of neuromuscular relaxants.
    Feldman SA
    Anaesthesia; 1997 Apr; 52(4):387-8. PubMed ID: 9135202
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible abnormal response to rocuronium in a patient taking multiple fitness supplements.
    Brett CN; Roberts SJ
    Anaesth Intensive Care; 2016 Sep; 44(5):640-1. PubMed ID: 27608352
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of time of day on the duration of neuromuscular blockade elicited by rocuronium.
    Cheeseman JF; Merry AF; Pawley MD; de Souza RL; Warman GR
    Anaesthesia; 2007 Nov; 62(11):1114-20. PubMed ID: 17924891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of myorelaxants in anesthesia.
    Flood P
    Curr Opin Pharmacol; 2005 Jun; 5(3):322-7. PubMed ID: 15907920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of neuromuscular function after a combination of mivacurium and rocuronium.
    Stout RG; Shine TS; Silverman DG; Brull SJ
    Yale J Biol Med; 2004 Sep; 77(5-6):149-54. PubMed ID: 15989744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
    Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
    Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose requirements of alfentanil to eliminate autonomic responses during rapid-sequence induction with thiopental 4 mg/kg and rocuronium 0.6 mg/kg.
    Abou-Arab MH; Rostrup M; Heier T
    J Clin Anesth; 2016 Dec; 35():465-474. PubMed ID: 27871575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology of rocuronium bromide (ORG 9426).
    Wicks TC
    AANA J; 1994 Feb; 62(1):33-8. PubMed ID: 8122487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer agents for rapid sequence intubation: etomidate and rocuronium.
    Ching KY; Baum CR
    Pediatr Emerg Care; 2009 Mar; 25(3):200-7; quiz 208-10. PubMed ID: 19287283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular and cardiovascular effects of neostigmine and methyl-atropine administered at different degrees of rocuronium-induced neuromuscular block.
    Van den Broek L; Proost JH; Wierda JM; Njoo MD; Hennis PJ
    Eur J Anaesthesiol; 1994 Nov; 11(6):481-7. PubMed ID: 7851356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the pharmacology of rocuronium bromide in experimental animals.
    Marshall RJ; Muir AW; Sleigh T; Savage DS
    Eur J Anaesthesiol Suppl; 1994; 9():9-15. PubMed ID: 7925216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of the interaction of rocuronium bromide with etomidate, fentanyl, midazolam, propofol, thiopentone, and isoflurane using closed-loop feedback control of infusion of rocuronium.
    Olkkola KT; Tammisto T
    Eur J Anaesthesiol Suppl; 1994; 9():99-100. PubMed ID: 7925218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical study of interaction between rocuronium and some commonly used antimicrobial agents.
    Cooper R; Maddineni VR; Mirakhur RK
    Eur J Anaesthesiol; 1993 Sep; 10(5):331-5. PubMed ID: 11767421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of volatile anaesthetics with rocuronium bromide in perspective.
    Agoston S
    Eur J Anaesthesiol Suppl; 1994; 9():107-11. PubMed ID: 7925200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationship of rocuronium bromide during intravenous anaesthesia.
    Mellinghoff H; Diefenbach C; Bischoff A; Grond S; Buzello W
    Eur J Anaesthesiol Suppl; 1994; 9():20-4. PubMed ID: 7925204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of rocuronium bromide in adult patients.
    Alvarez-Gomez JA; Estelles ME; Fabregat J; Perez F; Brugger AJ
    Eur J Anaesthesiol Suppl; 1994; 9():53-6. PubMed ID: 7925209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.